$3.32T
Total marketcap
$64.41B
Total volume
BTC 57.31%     ETH 12.14%
Dominance

Genscript Biotech GNNSF Stock

$1.67   -21.462261%
Add to favorites
Market Cap
$3.64B
LOW - HIGH [24H]
$2.12 - $2.12
VOLUME [24H]
$100.00
P/E Ratio
0
Earnings per share
-$0.04
Price   Prediction

Genscript Biotech Price Chart

Sorry, that's all we've gotfor now...

Genscript Biotech GNNSF Financial and Trading Overview

Genscript Biotech stock price 1.67 USD
Previous Close {summary_details__previousClose}
Open {summary_details__open}
Bid {summary_details__bid} x {summary_details__bidSize}
Ask {summary_details__ask} x {summary_details__askSize}
Day's Range 2.35 - 2.35 USD
52 Week Range 1.89 - 3.9 USD
Volume {summary_details__volume}
Avg. Volume {summary_details__averageVolume}
Market Cap {summary_details__marketCap}
Beta (5Y Monthly) {summary_details__beta}
PE Ratio (TTM) {summary_details__trailingPE}
EPS (TTM) -0.04 USD
Forward Dividend & Yield {summary_details__dividendRate} ({summary_details__dividendYield})
Ex-Dividend Date {summary_details__exDividendDate}
1y Target Est {financial_data__targetMeanPrice}

GNNSF Valuation Measures

Enterprise Value {default_key_statistics__enterpriseValue}
Trailing P/E {summary_details__trailingPE}
Forward P/E {summary_details__forwardPE}
PEG Ratio (5 yr expected) {default_key_statistics__pegRatio}
Price/Sales (ttm) {summary_details__priceToSalesTrailing12Months}
Price/Book (mrq) {default_key_statistics__priceToBook}
Enterprise Value/Revenue {default_key_statistics__enterpriseToRevenue}
Enterprise Value/EBITDA {default_key_statistics__enterpriseToEbitda}

Trading Information

Genscript Biotech Stock Price History

Beta (5Y Monthly) {default_key_statistics__beta}
52-Week Change {default_key_statistics__52WeekChange}
S&P500 52-Week Change {default_key_statistics__SandP52WeekChange}
52 Week High {summary_details__fiftyTwoWeekHigh}
52 Week Low {summary_details__fiftyTwoWeekLow}
50-Day Moving Average {summary_details__fiftyDayAverage}
200-Day Moving Average {summary_details__twoHundredDayAverage}

GNNSF Share Statistics

Avg. Volume (3 month) {summary_details__averageVolume}
Avg. Daily Volume (10-Days) {summary_details__averageDailyVolume10Day}
Shares Outstanding {default_key_statistics__sharesOutstanding}
Float {default_key_statistics__floatShares}
Short Ratio {default_key_statistics__shortRatio}
% Held by Insiders {default_key_statistics__heldPercentInsiders}
% Held by Institutions {default_key_statistics__heldPercentInstitutions}
Shares Short {default_key_statistics__sharesShort}
Short % of Float {default_key_statistics__shortPercentOfFloat}
Short % of Shares Outstanding {default_key_statistics__sharesPercentSharesOut}

Dividends & Splits

Trailing Annual Dividend Rate {summary_details__trailingAnnualDividendRate}
Trailing Annual Dividend Yield {summary_details__trailingAnnualDividendYield}
5 Year Average Dividend Yield {summary_details__fiveYearAvgDividendYield}
Payout Ratio {summary_details__payoutRatio}
Last Split Factor {default_key_statistics__lastSplitFactor}

Financial Highlights

Fiscal Year

Fiscal Year Ends {default_key_statistics__lastFiscalYearEnd}
Most Recent Quarter (mrq) {default_key_statistics__mostRecentQuarter}
Next Fiscal Year End {default_key_statistics__nextFiscalYearEnd}

Profitability

Profit Margin {financial_data__profitMargins}
Operating Margin (ttm) {financial_data__operatingMargins}
Gross Margin {financial_data__grossMargins}
EBITDA Margin {financial_data__ebitdaMargins}

Management Effectiveness

Return on Assets (ttm) {financial_data__returnOnAssets}
Return on Equity (ttm) {financial_data__returnOnEquity}

Income Statement

Revenue (ttm) {financial_data__totalRevenue}
Revenue Per Share (ttm) {financial_data__revenuePerShare}
Quarterly Revenue Growth (yoy) {financial_data__revenueGrowth}
Gross Profit (ttm) {financial_data__grossProfits}
EBITDA {financial_data__ebitda}
Net Income Avi to Common (ttm) {default_key_statistics__netIncomeToCommon}
Diluted EPS (ttm) {default_key_statistics__trailingEps}
Quarterly Earnings Growth (yoy) {default_key_statistics__earningsQuarterlyGrowth}

Balance Sheet

Total Cash (mrq) {financial_data__totalCash}
Total Cash Per Share (mrq) {financial_data__totalCashPerShare}
Total Debt (mrq) {financial_data__totalDebt}
Total Debt/Equity (mrq) {financial_data__debtToEquity}
Current Ratio (mrq) {financial_data__currentRatio}
Book Value Per Share (mrq) {default_key_statistics__bookValue}

Cash Flow Statement

Operating Cash Flow (ttm) {financial_data__operatingCashflow}
Levered Free Cash Flow (ttm) {financial_data__freeCashflow}

Profile of Genscript Biotech

Country United States
State {summary_profile__state}
City {summary_profile__city}
Address {summary_profile__address1}
ZIP {summary_profile__zip}
Phone {summary_profile__phone}
Website {summary_profile__website}
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees {summary_profile__fullTimeEmployees}

{summary_profile__longBusinessSummary}

Q&A For Genscript Biotech Stock

What is a current GNNSF stock price?

Genscript Biotech GNNSF stock price today per share is 1.67 USD.

How to purchase Genscript Biotech stock?

You can buy GNNSF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Genscript Biotech?

The stock symbol or ticker of Genscript Biotech is GNNSF.

Which industry does the Genscript Biotech company belong to?

The Genscript Biotech industry is Biotechnology.

How many shares does Genscript Biotech have in circulation?

The max supply of Genscript Biotech shares is 2.19B.

What is Genscript Biotech Price to Earnings Ratio (PE Ratio)?

Genscript Biotech PE Ratio is now.

What was Genscript Biotech earnings per share over the trailing 12 months (TTM)?

Genscript Biotech EPS is -0.04 USD over the trailing 12 months.

Which sector does the Genscript Biotech company belong to?

The Genscript Biotech sector is Healthcare.

✨New! Portfolio🚀